Audited by PwC
Income statement - the Novozymes Group
| Note | 2008 | 2007 | ||||||
| DKK million | DKK million | |||||||
| 1, | 2 | Revenue | 8,146 | 7,438 | ||||
| 3, | 5 | Cost of goods sold | 3,787 | 3,489 | ||||
| Gross profit | 4,359 | 3,949 | ||||||
| 3, | 5 | Sales and distribution costs | 1,061 | 921 | ||||
| 3, | 5 | Research and development costs | 1,096 | 995 | ||||
| 3, | 4, | 5 | Administrative costs | 745 | 675 | |||
| 6 | Other operating income, net | 47 | 123 | |||||
| Operating profit | 1,504 | 1,481 | ||||||
| 7 | Financial income | 263 | 130 | |||||
| 8 | Financial costs | 348 | 226 | |||||
| Profit before tax | 1,419 | 1,385 | ||||||
| 9 | Corporation tax | 357 | 343 | |||||
| Net profit | 1,062 | 1,042 | ||||||
| Attributable to: | ||||||||
| Shareholders in the parent company | 1,062 | 1,048 | ||||||
| Minority interests | - | (6) | ||||||
| 1,062 | 1,042 | |||||||
| Proposed dividend per share | DKK 5.25 | DKK 5.00 | ||||||
| 18 | Earnings per share | DKK 17.17 | DKK 16.93 | |||||
| 18 | Earnings per share, diluted | DKK 16.86 | DKK 16.47 | |||||
